Prospective Study of Estramustine Phosphate for Hormone Refractory Prostate Cancer Patients following Androgen Deprivation Therapy-Reference-Cited by-同舟云学术

Prospective Study of Estramustine Phosphate for Hormone Refractory Prostate Cancer Patients following Androgen Deprivation Therapy

Published:2005 Issue:1 Volume:75 Page:43-49
ISSN:0042-1138
Container-title:Urologia Internationalis
language:en
Short-container-title:Urol Int

Author:

Hirano Daisaku,Minei Sadatsugu,Kishimoto Yuichi,Yamaguchi Kenya,Hachiya Takahiko,Yoshida Toshio,Yoshikawa Tetsuo,Endoh Makoto,Yamanaka Yataroh,Yamamoto Tadao,Satoh Yasuo,Ishida Hajime,Okada Kiyoki,Takimoto Yukie

Publisher

S. Karger AG

Subject

Urology

Reference26 articles.

1. Smith DC, Dawson NA, Trump DL: Secondary hormonal manipulation; in Vogelzang NJ, Scardino PT, Shipley WU, Coffey DS (eds): Comprehensive Textbook of Genitourinary Oncology. Philadelphia, Lippincott Williams & Wilkins, 2000, pp 855-862.

2. Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.

3. Cytotoxic properties of estramustine unrelated to alkylating and steroid constituents

4. Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines du 145 and PC-3

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Androgen receptor axis‑targeted agents are not superior to conventional hormonal therapy for treatment of metastatic prostate cancer;Oncology Letters;2022-08-09

2. Estramustine Phosphate Monotherapy in Castration-Resistant Prostate Cancer Patients Who Cannot Receive Cytotoxic Chemotherapy;The Korean Journal of Urological Oncology;2020-08-31

3. Role of Estramustine Phosphate and Other Estrogens for Castration-Resistant Prostate Cancer;Hormone Therapy and Castration Resistance of Prostate Cancer;2018

4. Enzalutamide versus abiraterone as a first-line endocrine therapy for castration-resistant prostate cancer (ENABLE study for PCa): a study protocol for a multicenter randomized phase III trial;BMC Cancer;2017-10-10

5. Effective and Safe Administration of Low-Dose Estramustine Phosphate for Castration-Resistant Prostate Cancer;Clinical Genitourinary Cancer;2016-02